biguanides has been researched along with Diseases, Metabolic in 3 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dvorácskó, S | 1 |
| Herrerias, A | 1 |
| Oliverio, A | 1 |
| Bhattacharjee, P | 1 |
| Pommerolle, L | 1 |
| Liu, Z | 1 |
| Feng, D | 1 |
| Lee, YS | 1 |
| Hassan, SA | 1 |
| Godlewski, G | 1 |
| Cinar, R | 1 |
| Iyer, MR | 1 |
| Waltenberger, B | 1 |
| Mocan, A | 1 |
| Šmejkal, K | 1 |
| Heiss, EH | 1 |
| Atanasov, AG | 1 |
| Frol'kis, AV | 1 |
2 reviews available for biguanides and Diseases, Metabolic
| Article | Year |
|---|---|
Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders.
Topics: Biguanides; Biological Products; Cardiovascular Diseases; Drug Discovery; Humans; Hydroxymethylgluta | 2016 |
[Inhibition of intestinal absorption as a principle of the treatment of metabolic diseases].
Topics: Animals; Anticholesteremic Agents; Biguanides; Deferoxamine; Dogs; Humans; Intestinal Absorption; Li | 1989 |
1 other study available for biguanides and Diseases, Metabolic
| Article | Year |
|---|---|
Cannabinoformins: Designing Biguanide-Embedded, Orally Available, Peripherally Selective Cannabinoid-1 Receptor Antagonists for Metabolic Syndrome Disorders.
Topics: AMP-Activated Protein Kinases; Animals; Biguanides; Cannabinoid Receptor Antagonists; Cannabinoids; | 2023 |